跳至主要内容
临床试验/JPRN-jRCTs051180203
JPRN-jRCTs051180203进行中(未招募)2 期

A phase 2 study of the decision of surgical adjustment time based on IDRF (Image Defined Risk Factors), and chemotherapy that gradually improve strength for intermediate risk neuroblastoma - A phase 2 study for intermediate risk neuroblastoma based on IDRF (Image Defined Risk Factors)

iehara tomoko0 个研究点目标入组 75 人开始时间: 2019年3月27日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 <= 18age old(—)
性别
All

入选标准

  • Patients with INSS stage 3 without MYCN amplification, who include children over12 months with favorable histology and 12 to 18 months with unfavorable histology.
  • Patients with INSS stage 4 without MYCN amplification, who include children under 12 months and 12 to 18 months with favorable histology and DNAindex>1
  • Patients with INSS stage 4s without MYCN amplification, who include children under 12 months with unfavolable histology or favorable histology and DNAindex=1

排除标准

  • (1) duplicated cancer cases. (2) A pregnant woman or a woman who may be pregnant or a lactating woman. (3) cases are merging psychoses or psychiatric symptoms. (4) cases who considers a disease, severe complication, or severe malformation that a doctor deems inappropriate to participate in this study. (5) cases of respiratory failure requiring intubation, cases with coagulopathy presenting DIC and the like

研究者

发起方
iehara tomoko

相似试验

A phase 2 study for intermediate risk neuroblastoma... | 临床试验